Tema Etfs LLC Makes New $2.64 Million Investment in Intuitive Surgical, Inc. $ISRG

Tema Etfs LLC purchased a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund purchased 5,912 shares of the medical equipment provider’s stock, valued at approximately $2,644,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of ISRG. Tobam increased its position in shares of Intuitive Surgical by 666.7% in the 2nd quarter. Tobam now owns 46 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 40 shares during the last quarter. Kilter Group LLC bought a new position in shares of Intuitive Surgical during the second quarter worth about $27,000. Princeton Global Asset Management LLC bought a new position in shares of Intuitive Surgical during the second quarter worth about $30,000. Riggs Asset Managment Co. Inc. grew its stake in Intuitive Surgical by 84.2% in the second quarter. Riggs Asset Managment Co. Inc. now owns 70 shares of the medical equipment provider’s stock worth $38,000 after purchasing an additional 32 shares in the last quarter. Finally, First Command Advisory Services Inc. increased its holdings in Intuitive Surgical by 3,750.0% in the second quarter. First Command Advisory Services Inc. now owns 77 shares of the medical equipment provider’s stock valued at $42,000 after buying an additional 75 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Trading Down 2.3%

Shares of NASDAQ:ISRG opened at $572.74 on Tuesday. The firm’s 50 day moving average is $566.53 and its two-hundred day moving average is $511.65. The firm has a market capitalization of $205.32 billion, a P/E ratio of 75.76, a PEG ratio of 4.77 and a beta of 1.67. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.99 by $0.41. The business had revenue of $2.51 billion during the quarter, compared to analyst estimates of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The business’s revenue for the quarter was up 22.9% compared to the same quarter last year. During the same period in the prior year, the company posted $1.84 EPS. Analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Buying and Selling

In other news, EVP Myriam Curet sold 7,562 shares of the firm’s stock in a transaction on Tuesday, October 28th. The stock was sold at an average price of $548.43, for a total transaction of $4,147,227.66. Following the transaction, the executive vice president directly owned 353 shares of the company’s stock, valued at approximately $193,595.79. This trade represents a 95.54% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Mark Brosius sold 4,500 shares of the company’s stock in a transaction dated Friday, December 12th. The stock was sold at an average price of $547.36, for a total transaction of $2,463,120.00. Following the completion of the sale, the senior vice president directly owned 907 shares of the company’s stock, valued at $496,455.52. The trade was a 83.23% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 114,007 shares of company stock valued at $63,533,844. Company insiders own 0.70% of the company’s stock.

Analyst Ratings Changes

Several brokerages have recently commented on ISRG. Robert W. Baird set a $655.00 target price on Intuitive Surgical in a research report on Wednesday, October 22nd. Leerink Partners raised their price objective on Intuitive Surgical from $593.00 to $600.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 22nd. Hsbc Global Res upgraded shares of Intuitive Surgical to a “strong-buy” rating in a research note on Thursday, October 23rd. Jefferies Financial Group increased their target price on shares of Intuitive Surgical from $550.00 to $560.00 and gave the stock a “hold” rating in a report on Wednesday, October 22nd. Finally, Evercore ISI set a $580.00 price target on shares of Intuitive Surgical in a research report on Monday, January 5th. Two analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $622.17.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.